Selventa CEO David de Graaf has been selected to serve on the scientific advisory board of the Massachusetts Institute of Technology's Center for Cancer Systems Biology.
MIT's CCSB is one of 10 formed under the National Cancer Institute's Integrative Cancer Biology Program that focus on developing and implementing computational models to analyze cancer as a complex biological system.